Inhibitory effects of polyprenoic acid (E5166) on production and secretion of alpha-fetoprotein and on cell kinetics in human hepatoma cells.
We investigated the effects of polyprenoic acid, E5166, on the production and secretion of alpha-fetoprotein (AFP) and on cell kinetics in a human hepatoma cell line (HuH-7). The cellular AFP content, measured flow cytometrically for cells stained by an indirect immunofluorescence method, was decreased by treatment with E5166. AFP in the culture medium decreased exponentially during exposure of cells to the drug. These changes were dose-dependent. The growth of HuH-7 cells in vitro was clearly suppressed in the presence of E5166. The inhibition of growth depended on the concentration of the agent. The fraction of S phase cells decreased relatively in the cells treated with a high concentration of the drug, whereas it increased in the cells treated with lower doses.
K
K
Sasaki
S
S
Kawasaki
K
K
Okita
T
T
Murakami
T
T
Takemoto
M
M
Takahashi
D006528:Carcinoma, Hepatocellular / Q000378:metabolism* / Q000473:pathology; D002453:Cell Cycle / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D005434:Flow Cytometry; D005786:Gene Expression Regulation; D006801:Humans; D008113:Liver Neoplasms / Q000378:metabolism* / Q000473:pathology; D014212:Tretinoin / Q000031:analogs & derivatives* / Q000494:pharmacology; D000509:alpha-Fetoproteins / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism
D000509:alpha-Fetoproteins; D014212:Tretinoin; C034534:3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid